LL-37
Explore the researchResearch Guides
Research GuidesAntimicrobial activity is not proof of infection treatmentHow to distinguish LL-37 laboratory findings from evidence needed to replace or supplement clinical anti-infective care.Read guide →Research GuidesCan bacteria be less susceptible to LL-37? A surface-chemistry exampleWhy a host-defense origin does not establish resistance-proof activity against every bacterial strain.Read guide →Research GuidesLL-37 and biofilms: identify the model before the claimA reader’s guide to attachment, biofilm biomass, bacterial growth and the limits of laboratory antibiofilm findings.Read guide →Research GuidesLL-37 and cancer: opposite findings can both require contextSeparate ovarian and colon experimental models, human tissue associations and a tiny intratumoral trial record.Read guide →Research GuidesHCAP-18 and LL-37: why the precursor is not the finished peptideUnderstand the original protein-processing research and why gene expression does not establish administered-peptide benefit.Read guide →Research GuidesLL-37 and innate immunity: activation is not automatically beneficialUnderstand why LL-37’s immune signaling cannot be reduced to a general immune-boosting claim.Read guide →Research GuidesLL-37 in periodontal fluid: delivery depends on what happens locallyRead the gingival-fluid and saliva experiments without turning them into a periodontitis treatment claim.Read guide →Research GuidesLL-37 as an autoantigen: what the psoriasis T-cell study meansUnderstand antigen recognition without confusing it with allergy, an injection-risk estimate or an immune-health benefit.Read guide →Research GuidesRosacea research shows why peptide processing mattersSeparate human skin observations and mouse experiments from claims about using LL-37 for redness or skin repair.Read guide →Research GuidesLL-37 safety: route and formulation belong in the first questionRead FDA’s current safety entry without mistaking withdrawn nomination status or topical tolerability for approval.Read guide →Research GuidesLL-37 wound-healing trials: the larger study was negative overallRead the small early topical trial alongside HEAL LL-37, including its full-cohort result and post hoc subgroup.Read guide →Research GuidesVitamin D and cathelicidin: a pathway is not a supplement prescriptionRead the human-cell mechanism studies without assuming vitamin D, endogenous LL-37 and injected peptide are interchangeable.Read guide →